Taiwan Pharmaceutical Market Outlook 2013


Posted March 5, 2014 by matildefernandes

The Taiwan Pharmaceutical Market Outlook report focuses on the Taiwanese pharmaceutical market, providing market analysis and a forecast to 2018.

 
[b]Summary[/b]

GBI Research, the leading business intelligence provider, has released its latest research "Taiwan Pharmaceutical Market Outlook 2013". The report focuses on the Taiwanese pharmaceutical market, providing market analysis and a forecast to 2018. It provides details on the various market drivers and healthcare trends that influence growth in Taiwans pharmaceutical industry. The report also profiles major biopharmaceutical companies in the country, both domestic and overseas players.

Taiwans pharmaceutical market was worth $4.4 billion in 2012, having grown at a CAGR of 2.9%, and is estimated to reach $5.5 billion by 2018, growing at a CAGR of 3.9%. Although the size of the market is small compared with other growing markets in Asia, it is expected to provide a market entry point for companies wishing to launch their products in other larger markets.


[b]Scope[/b]

* Political, economic and investment environment in Taiwan
* Healthcare and insurance system, healthcare infrastructure and key policy initiatives
* Market size estimation, analysis of key therapeutic areas and emerging areas
* Profiles of major biopharmaceutical companies in Taiwan, such as Pfizer, Sanofi Aventis, GSK and Novartis, and key domestic players such as China Chemical & Pharmaceutical Company, Standard Chemicals & Pharmaceuticals and Yung Shin Pharmaceutical.
* Key drivers and barriers that have had a significant impact on the market


[b]Reasons to buy[/b]

* Identify potential therapeutic areas in Taiwan that are poised for growth
* Build effective market entry and expansion strategies for introducing products in Taiwan
* Develop key strategic initiatives by studying top competitors key strategies
* Reinforce R&D pipelines by identifying new target mechanisms that can produce first-in-class molecules with more efficacy and better safety


[b]To order this report:[/b]

Email: [email protected]
US: +1 866 325 7446
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com


[b]RELATED LINK:[/b]

http://www.researchonglobalmarkets.com/taiwan-pharmaceutical-market-outlook-2013.html
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Research On Global Markets
Website Research On Global Markets
Phone +912240987600
Business Address Post Office Lane
Mumbai
Country India
Categories Business , Reports , Research
Tags healthcare and insurance system , healthcare infrastructure , investment environment in taiwan , major biopharmaceutical companies , market analysis and a forecast , market drivers and healthcare trends , taiwan pharmaceutical market outlook 2013 , taiwanese pharmaceutical market
Last Updated March 5, 2014